
Telbrit AH 40mg/5mg/12.5mg Tablet
Marketer
Elbrit Life Sciences
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telbrit AH 40mg/5mg/12.5mg Tablet
Hypertensia-AH 40mg/5mg/12.5mg tablets combine multiple medications to manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. Hypertensia-AH may be taken with or without food; dosage is individualized based on your response and health status. Maintain consistent daily timing. Continue treatment as directed by your physician; discontinuation may increase stroke or heart attack risk. The medication includes a diuretic, increasing urination; avoid dosing within four hours of bedtime. Consistent use, even during asymptomatic periods, maximizes therapeutic benefit. Common side effects include headache, dizziness, fatigue, altered taste, flu-like symptoms, diarrhea, and sinusitis. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to minimize potential muscle weakness, dry mouth, or thirst. Prior to commencing treatment, inform your doctor of any kidney or liver conditions, pregnancy, breastfeeding, or other medications, particularly those for hypertension or heart disease. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood sugar is essential to ensure treatment efficacy.
Primary Ingredients of Telbrit AH 40mg/5mg/12.5mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Telbrit AH 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Telbrit AH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telbrit AH 40mg/5mg/12.5mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Telbrit AH 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telbrit AH 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telbrit AH 40mg/5mg/12.5mg Tablet whole; avoid crushing, chewing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
How Telbrit AH 40mg/5mg/12.5mg Tablet works:
Each Telbrit AH 40mg/5mg/12.5mg tablet combines telmisartan, amlodipine, and hydrochlorothiazide to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both act to dilate blood vessels, thus reducing blood pressure. Hydrochlorothiazide, a diuretic, lowers blood pressure by increasing urine output, eliminating excess fluid and electrolytes, and contributing to vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telbrit AH 40mg/5mg/12.5mg tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Use of Telbrit AH 40mg/5mg/12.5mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Telbrit AH 40mg/5mg/12.5mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Telbrit AH 40mg/5mg/12.5mg Tablets, which can induce side effects including dizziness, headaches, nausea, or fatigue. These side effects can compromise concentration and driving safety.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telbrit AH 40mg/5mg/12.5mg tablets, as dose modification may be necessary. Medical advice is recommended. Telbrit AH 40mg/5mg/12.5mg tablets are not advised for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Telbrit AH 40mg/5mg/12.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Telbrit AH 40mg/5mg/12.5mg Tablet :
Should you forget a Telbrit AH 40mg/5mg/12.5mg Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed dosage.
Facts to Know About Telbrit AH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |
